Reflux esophagitis is a chronic disorder characterized by the symptoms of heartburn and regurgitation. Heartburn is extremely common in the United States, reportedly experi- enced by approximately 1/3 of the population on a monthly basis and by approximately 1/12 of the population on a daily basis. In addition to heartburn and other symptoms, reflux esophagitis has importance because it results in injury to the esophageal tissues ranging from inflammation to ulceration and healing of these lesions occasionally produces such undesirable complications as stricture formation and the development of the premalignant columnar-lined (Barrett’s) esophagus.
KeywordsReflux Disease Reflux Esophagitis Lower Esophageal Sphincter Pressure Esophageal Epithelium Prolonged Contact
Unable to display preview. Download preview PDF.
- 8.Pace F, Lazzaroni M, Bianci Porro G: Failure of sucralfate in the treatment of refractory esophagitis versus high dose famotidine. An endoscopic study. Scand J Gastroenterol 26:491–494, 1991. This article demonstrates the inability of sucralfate to heal lesions in patients refractory to an H2RA.PubMedCrossRefGoogle Scholar
- 9.Schotborgh RH, Hameeteman W, Dekker W, et al: Combination therapy of sucralfate and cimetidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis. Am J Med 86(suppl 6A):77–80, 1989. This article indicates that the combination of sucralfate with an H2RA offers minimal advantages over sucralfate alone and that sucralfate in low dose is unable to prevent relapse of reflux esophagitis.PubMedCrossRefGoogle Scholar